source
- Rare disease drugmakers brace for potential Trump administration price cuts amid GOP push on health‑care fraudRare disease drugmakers are watching the Trump administration closely as proposals emerge that could force lower prices for their specialty therapies. The companies are exploring strategies to miti…
- Advocates warn federal HIV prevention funding cuts could force community groups to closeCommunity-based organizations that deliver HIV testing and prevention tools are urging federal health officials to restore a key funding program that recently expired. Advocates say the lapse thre…